Stroke healing period boosted by a course of Prozac

Giving stroke individuals Prozac quickly immediately after the event could support their recovery from paralysis, a study has discovered.

Researchers found more improvement in movement and better independence immediately after three months in individuals taking the antidepressant (also known as fluoxetine), compared to placebo.

The Lancet Neurology study was depending on investigation on 118 individuals in France.

UK stroke experts mentioned the findings were "promising".

This was the greatest study of selective serotonin re-uptake inhibitors (SSRIs) and stroke recovery to date.

Tests on stroke individuals 90 days immediately after becoming provided the drug discovered that individuals taking fluoxetine had acquired significantly more operate in their upper and decrease limbs than individuals who weren't provided the drug.

Sufferers within the fluoxetine group were also more more likely to be coping independently.

All individuals within the study had moderate to serious motor disabilities following their stroke.
'Dual advantage?'

The study mentioned that the side-effects from the antidepressant were usually gentle and infrequent, even though this group did notice more cases of nausea and diarrhoea.

The authors, led by Professor François Chollet, mentioned: "The constructive effect in the drug on motor operate of recovering individuals suggests that the... action of SSRIs delivers a whole new pathway that should be explored further within the therapy of acute ischaemic stroke."

Every year within the UK a hundred and fifty,000 individuals have a stroke and also a 3rd of these will probably be left that has a disability like paralysis down a single side of their human body.

Dr Sharlin Ahmed, investigation liaison officer in the UK Stroke Association, mentioned: "We are regularly seeking for new treatment options which can boost the outcomes for stroke survivors plus the benefits of this investigation glimpse promising.

"Antidepressants, like fluoxetine, might be used to treat stroke individuals with depression that is a typical side effect of stroke, so it really is very fascinating to find out that this already licensed drug could have a dual advantage.

"However, further investigation requirements to become undertaken ahead of the usage of this antidepressant might be accepted as an efficient therapy for bettering movement following a stroke."